Fig. 3From: Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-COREMean durations of daptomycin treatment by primary infection over time (2005–2012). cSSTI complicated skin and soft tissue infection, FBPI foreign body/prosthetic infectionBack to article page